31.1, 23.6, 19.2, 18.2. IR (CHCl3) n 3412.2, 3309.7, 2400.0,
1698.0, 1681.0, 1659.6, 1582.7, 1522.9, 1450.3 cmꢁ1
Acknowledgements
.
The Centre for Parallel Computers (PDC) at the Royal Insti-
tute of Technology (KTH), Stockholm, Sweden, is acknowl-
edged for a generous allotment of computing time. We thank
G. Lindeberg, A. Johansson, and E. Akerblom for helpful dis-
cussions.
2-[20-(200-Acetylamino-300-methylbutyrylamino)phenylethynyl]-
N-(1-methylcarbamoylethyl)benzamide (7). Compound 6 (373.0
mg, 1.0 mmol) was dissolved in dichloromethane (14 mL), di-
isopropylethylamine (1.57 mL, 0.12 mol) and HATU (943.3
mg, 4.0 mmol) was added, and the mixture was stirred for 1
h. 2-Amino-N-methylpropionamide (411.5 mg, 4.0 mmol)
dissolved in a mixture of dimethylformamide (3 mL), dichloro-
methane (1 mL), and diisopropylethylamine (0.1 mL) was
added and the solution was stirred for 140 min. Then, the reac-
tion mixture was poured into 0.1 M aqueous HCl (5–10 mL).
The mixture was extracted three times with diethyl ether (5–10
mL). The combined organic layers were washed with conc.
aqueous NaHCO3 solution (5–10 mL) and water (5–10 mL),
re-extracting the aqueous phases twice in each case with
diethyl ether, filtered through magnesium sulfate, and then
concentrated under reduced pressure. Thereafter, the residue
was purified by flash chromatography (silica gel 60, particle
size 0.040–0.063 mm, Merck; ethyl acetate). The combined
product fractions were concentrated on a rotatory evaporator.
The diastereomeric mixture was separated by HPLC using
ethyl acetate as eluent, giving 129.1 mg of compound 7a and
107.1 mg of 7b, 51% yield (236.2 mg, 0.1 mmol).
˚
References
1
2
N. C. J. Strynadka, S. E. Jensen, P. M. Alzari and M. N. G.
James, Nat. Struct. Biol., 1996, 3, 290.
(a) J. D. Puglishi, L. Chen, S. Blanchard and A. D. Frankel,
Science, 1995, 270, 1200; (b) G. Variani Acc. Chem. Res., 1997,
30, 189.
3
4
(a) P. E. Floreancing, S. E. Swalley, J. W. Trauger and P. B. Der-
van, J. Am. Chem. Soc., 2000, 122, 6342; (b) R. E. Bremer, J. W.
Szewczyk, E. E. Baird and P. B. Dervan, Bioorg. Med. Chem.,
2000, 8, 1947–1955.
(a) J. Collinge Annu. Rev. Neurosci., 2001, 24, 519; (b) M. Mihara,
Y. Takahashi and A. Ueno, Biopolymers, 1998, 47, 83; (c) K. M.
Pan, M. Baldwin, J. Nguyen, M. Gasset, A. Serban, D. Groth, I.
Mehlhorn, Z. Huang, R. J. Fletterick, F. E. Cohen and S. B. Pru-
siner, Proc. Natl. Acad. Sci. U. S. A., 1993, 90, 10 962; (d ) R.
Riek, S. Hornemann, G. Wider, M. Billeter, R. Glockshuber
and K. Wuthrich, Nature, 1996, 382, 180.
5
(a) L. C. Serpell, C. C. F. Blake and P. E. Fraser, Biochemistry,
2000, 39, 13 269; (b) S. Ohnisiki, A. Koide and S. Koide, J.
Mol. Biol., 2000, 301, 477; (c) D. R. Booth, M. Sunde, V. Bellotti,
C. V. Robinson, W. L. Hutchinson, P. E. Fraser, P. N. Hawkins,
C. M. Dodson, S. E. Radford, C. C. F. Blake and B. M. Pepys,
Nature, 1997, 385, 787.
(S,S)-2-[20-(200-Acetylamino-300-methylbutyrylamino)pheny-
lethynyl]-N-(1-methylcarbamoylethyl)benzamide (7a). 1H
NMR (400 MHz, CDCl3 , 25 ꢂC): d 9.33 (br s, 1H; NH), 8.61
6
7
J. M. McDonnell, D. Fushman, S. M. Cahill, B. J. Sutton and D.
Cowburn, J. Am. Chem. Soc., 1997, 119, 5321.
3
3
[d, J(H,H) ¼ 8.4 Hz, 1H; ArH], 7.91 [d, J(H,H) ¼ 4.7 Hz,
1H; NH], 7.63–7.68 (m, 2H; ArH), 7.46–7.53 (m, 2H; ArH),
7.33–7.40 (m, 2H; ArH), 7.14 [d, 3J(H,H) ¼ 8.1 Hz; NH],
7.06 [dd, 3J(H,H) ¼ 7.5, 7.5 Hz, 1H; ArH], 6.60 [d,
3J(H,H) ¼ 9.3 Hz, 1H; NH], 5.50 [dd, 3J(H,H) ¼ 5.2, 9.3
(a) J. P. Derrick, G. J. Davies, Z. Dauter, K. S. Wilson and D. B.
Wigley, J. Mol. Biol., 1992, 227, 1253; (b) J. P. Derrick and D. B.
Wigley, Nature, 1992, 359, 752; (c) J. P. Derrick and D. B. Wigley,
J. Mol. Biol., 1994, 243, 906; (d ) C. Boutillon, R. Wintjens, G.
Lippens, H. Drobecq and A. Tartar, Eur. J. Biochem., 1995,
231, 166; (e) E. L. McCallister, E. Alm and D. Baker, Nat. Struct.
Biol., 2000, 7, 669.
3
Hz, 1H; Val-CHa], 5.32 [dq, J(H,H) ¼ 6.8, 8.4 Hz, 1H; Ala-
CHa], 2.76 [d, 3J(H,H) ¼ 4.7 Hz, 3H; CH3NHAla], 2.33 [dh,
3J(H,H) ¼ 5.2, 6.6 Hz, 1H; Val-CHb], 2.1 (s, 3H, CH3COVal),
1.49 [d, 3J(H,H) ¼ 6.8 Hz, 3H; Ala-CH3], 1.05 [d,
3J(H,H) ¼ 6.6 Hz, 3H; Val-CH3g], 0.95 [d, 3J(H,H) ¼ 6.6
8
9
(a) P. D. Kwong, R. Wyatt, J. Robinson, R. W. Sweet, J. Sodroski
and W. A. Hendrickson, Nature, 1998, 393, 648; (b) A. Cochran,
R. T. Tong, M. A. Starovanski, E. J. Park, R. S. McDowell, J. E.
Theaker and N. J. Skelton, J. Am. Chem. Soc., 2001, 123, 625.
(a) B. Odaert, F. Jean, C. Boutillon, E. Buisine, O. Melnyk, A.
Tartar and G. Lippens, Protein Sci., 1999, 8, 2773; (b) C. Das,
S. Raghothama and P. Balaram, J. Am. Chem. Soc., 1998, 120,
13
Hz, 3H; Val-CH3g]. C NMR (100 MHz, CDCl3 , 25 ꢂC) d
173.5,171.3, 170.6, 166.5, 140.3, 135.2, 133.9, 132.3, 130.9,
129.8, 128.3, 127.3, 123.4, 122.3, 119.4, 112.1, 94.9, 89.5,
57.7, 48.5, 32.8, 26.0, 23.7, 20.4, 19.2, 17.2. MS (30 eV, ESI):
m/z (%) 463 (100) [M ꢁ H]+. IR (CHCl3) n 3412.9, 3307.1,
´
5812; (c) E. Alba, A. Jimenez and M. Rico, J. Am. Chem. Soc.,
1997, 119, 175.
10 (a) H. J. Dyson and P. E. Wright, Annu. Rev. Biophys. Chem.,
1991, 20, 519; (b) V. Munoz and L. Serrano, Proteins, 1994, 20,
301; (c) T. P. Quinn, N. B. Tweedy, R. W. Williams, J. S. Richard-
son and D. C. Richardson, Proc. Natl. Acad. Sci. U. S. A., 1994,
91, 8747.
11 (a) B. L. Sibanda and J. M. Thornton, J. Mol. Biol., 1993, 229,
428; (b) B. L. Sibanda and J. M. Thornton, Nature, 1985, 316,
170
2972.5,
2935.8,
2876.4,
1648.7,
1578.9,
1514.2
cmꢁ1.[a]2D0 ¼ +64ꢂ (c ¼ 1, CHCl3).
(R,S)-2-[20-(200-Acetylamino-300-methylbutyrylamino)phenyl-
ethynyl]-N-(1-methylcarbamoylethyl)benzamide (7b). 1H
NMR (400 MHz, CDCl3 , 25 ꢂC): d 9.68 (br s, 1H; NH), 8.63
3
3
[d, J(H,H) ¼ 8.4 Hz, 1H; ArH], 7.89 [d, J(H,H) ¼ 4.7 Hz,
1H; NH], 7.71 [d, 3J(H,H) ¼ 7.7 Hz, 1H; ArH], 7.65 [d,
3J(H,H) ¼ 7.5 Hz, 1H; ArH], 7.45–7.52 (m, 2H; ArH), 7.30–
7.42 (m, 2H; ArH), 7.06 [t,3J(H,H) ¼ 7.5 Hz, 1H; ArH], 6.96
[d, 3J(H,H) ¼ 9.0 Hz; NH], 6.68 [d, 3J(H,H) ¼ 9.1 Hz, 1H;
NH], 5.65 [dd, 3J(H,H) ¼ 4.4, 9.1 Hz, 1H; Val-CHa], 5.26
[dq,3J(H,H) ¼ 7.0, 9.0 Hz, 1H; Ala-CHa], 2.81 [d,
3J(H,H) ¼ 4.7 Hz, 3H; CH3NHAla], 2.25 [dh,3J ¼ 4.4, 6.8 Hz,
12 For reviews on b-hairpin mimetics, see: (a) M. S. Searle J. Chem.
Soc., Perkin Trans. 2, 2001, 1011; (b) J. A. Robinson Synlett,
1999, 4, 429; (c) J. S. Nowick, E. M. Smith and M. Pairish, Chem.
Soc. Rev., 1996, 401.
13 (a) D. L. Minor, Jr. and S. P. Kim, Nature, 1994, 367, 660; (b)
C. K. Smith, J. M. Withka and L. Regan, Biochemistry, 1994,
33, 5510; (c) P. Y. Chou and G. D. Fasman, Biochemistry,
1973, 13, 211; (d ) K. Smith and L. Regan, Acc. Chem. Res.,
1997, 30, 153; (e) K. Gunasekaran, C. Ramakrishnan and P.
Balaram, Protein Eng., 1997, 10, 1131.
1H; Val-CHb], 2.1 (s, 3H; CH3COVal), 1.36 [d, J(H,H) ¼ 7.0
3
Hz, 3H; Ala-CH3], 0.94 [d, 3J(H,H) ¼ 6.8 Hz, 3H; Val-
14 S. J. Russel and A. G. Cochran, J. Am. Chem. Soc., 2000, 123,
625.
3
CH3g], 0.87 [d, J(H,H) ¼ 6.8 Hz, 3H; Val-CH3g]. 13C NMR
15 (a) I. Pozdnyakova, J. Guidry and P. Wittung-Stafshede, J. Am.
Chem. Soc., 2000, 122, 6337; (b) A. C. Gibbs, L. H. Kondejewski,
W. Gronwald, A. M. Nip, R. S. Hodges, B. D. Sykes and D. S.
Wishart, Nat. Struct. Biol., 1998, 5, 284; (c) D. Tolkatchev, A.
Ng, W. Vranken and F. Ni, Biochemistry, 2000, 39, 2878.
16 (a) M. J. Soth and J. S. Nowick, J. Org. Chem., 1999, 64, 276; (b)
S. C. Shankaramma, S. K. Singh, A. Sathyamurthy and P.
Balaram, J. Am. Chem. Soc., 1999, 121, 5360; (c) T. S. Haque,
J. C. Little and S. H. Gellman, J. Am. Chem. Soc., 1996, 118,
(100 MHz, CDCl3 , 25 ꢂC) d 173.6, 171.4, 170.3, 166.3, 140.8,
135.6, 133.3, 132.0, 130.8, 129.8, 128.3, 127.0, 123.3, 122.3,
119.3, 112.0, 94.6, 89.6, 57.3, 48.5, 33.2, 26.0, 23.7, 19.9,
19.3, 17.0. MS (30 eV, ESI): m/z (%) 463 (46) [M ꢁ H]+, 432
(24), 322 (100), 291 (9), 263 (7). IR (CHCl3) n 3413.3, 3307.6,
2973.3, 2933.5, 2875.2, 1653.0, 1580.0, 1517.7 cmꢁ1
[a]2D0 ¼ ꢁ64ꢂ (c ¼ 1, CHCl3).
.
842
New J. Chem., 2002, 26, 834–843